Table 1.
Summary of Pleural Diagnoses in 315 patients subject to routinely acquired and reported Computed Tomography imaging for suspected Pleural Malignancy.
| Pleural Malignancy (n = 195, 62%) | Benign Disease (n = 120, 38%) |
|---|---|
| Mesothelioma (n = 59, 19%) | BAPE (n = 23, 7%) |
| Secondary Malignancies (n = 137, 43%) | Pleural Infection (n = 12, 4%) |
| Lung Cancer (n = 74, 23%) | Reactive assoc. with Lung Cancer (n = 12, 4%) |
| Breast Cancer (n = 14, 4%) | Cardiac or Liver Transudates (n = 23, 7%) |
| Renal Cancer (n = 8, 3%) | Fibrothorax (n = 5, 2%) |
| Haematological Cancer (n = 7, 2%) | Tuberculous Pleuritis (n = 7, 2%,) |
| Gynaecological Cancer (n = 8, 3%) | Inflammatory Pleuritis (n = 9, 3%) |
| Other defined malignancy (n = 17, 5%) | Pulmonary Thromboembolism (n = 1, 0.3%) |
| Unknown Primary (n = 9, 3%) | Drug-related (n = 1, 0.3%) |
| Chylothorax (n = 1, 0.3%) | |
| Post-cardiac surgery (n = 1, 0.3%) | |
| Pancreatitis (n = 1, 0.3%) | |
| Reactive secondary to Fibroids (n = 1, 0.3%) | |
| Post-lobectomy (n = 2, 0.6%) | |
| No specific diagnosis madea (n = 21, 6.6%) |
BAPE; Benign Asbestos-related Pleural Effusion.
a
with reassuring clinical follow-up of at least 6 months.